NCT00249197View on ClinicalTrials.gov

A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

413

Participants

Timeline

Start Date

January 31, 1997

Study Completion Date

July 31, 1998

Conditions
Skin Diseases, Bacterial
Interventions
DRUG

levofloxacin

All Listed Sponsors
collaborator

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00249197 - A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections | Biotech Hunter | Biotech Hunter